Summer is just around the corner, bringing longer days and warmer weather. But if you’re one of the 650,000+ Australians suffering from excessive sweating (hyperhidrosis), the thought of a long hot summer might fill you with dread.
Hyperhidrosis is a common – and often embarrassing – problem, with the axillary (underarm) region being the leading culprit, followed by the palms and feet. Many sufferers complain of obvious sweat patches on clothes and generally feeling uncomfortable. In severe cases, it can be socially debilitating and have a real impact on quality of life.
There is a growing demand for a treatment that provides a lasting, non-surgical result. In the past, treatment options were limited to temporary solutions ranging in effectiveness. As a last resort, surgery was also an option. The new miraDry treatment changes all of this.
In what can truly be described as groundbreaking, miraDry delivers a solution to everyday sweat and hyperhidrosis.
miraDry is the first and only TGA registered device for use in the axillae (underarms) for treating excessive underarm sweat.
It is a non-surgical treatment performed in-clinic that uses microwave-based technology, which is targeted at the depth of the large sweat glands in the axilla. The controlled microwave energy then radiates and destroys targeted sweat glands.
miraDry treatment destroys 22,000 to 30,000 underarm sweat glands, reducing sweat volume by an average of 82 percent. The procedure is long lasting (if not permanent) and can be used on all skin types. The majority of patients only require one treatment.
There is no downtime post-procedure, however heavy exercising should be avoided for 72 hours.
miraDry isn’t just for hyperhidrosis sufferers – anyone bothered by underarm sweating, sensitive to antiperspirants or wanting to avoid the embarrassment of sweat patches is suitable.
This year, sail through summer comfortable and dry. With miraDry, you don’t have to sweat the small stuff!
Talk to one of our staff members today about this ingenious sweat solution.